Oct 2026· Archives of Clinical Neuropsychology· 0 citations
TL;DR
Compared to PD, PSP demonstrates a more severe neuropsychological profile marked by frontal and visuospatial deficits, which can improve diagnostic accuracy, early intervention, and differential diagnosis across diverse populations.
Abstract
Objective: Progressive supranuclear palsy (PSP) and Parkinson’s disease (PD) are neurodegenerative disorders with overlapping features, frequently leading to diagnostic uncertainty. PSP is associated with rapid progression, frontal-subcortical dysfunction, and impairments in gait, speech, and cognition. Accurate neuropsychological differentiation is critical given the diseases’ diverging prognoses and treatments. This review aimed to identify neuropsychological features that distinguish PSP from PD, assessment tools sensitive to PSP-specific decline, and sociodemographic factors influencing disease presentation. Method/Data Selection: Literature was obtained via searches of journals in the following databases: APA PsycInfo and Google Scholar, using combinations of the following search terms: ‘Progressive Supranuclear Palsy’, ‘Parkinson’s, ‘Neurocognitive Profile’, ‘Cultural Factors.’ A total of 11 peer-reviewed journal articles from 2009 – 2025 were deemed eligible for inclusion. Results/Data Synthesis: A review of findings suggests PSP is associated with earlier and more severe impairment in executive functioning, cognitive flexibility, inhibition, visuospatial processing, and working memory. Specific assessments (e.g., Digit Span, Stroop, etc.) demonstrated sensitivity to PSP-related decline. PSP patients also exhibited distinct gait abnormalities (reduced cadence and vertical displacement) and speech features (slower articulation rate, increased hesitancy, and altered phonation). Apathy was more severe in PSP. Cultural and geographic factors influenced age of onset, symptom profile, and genetic expression. Conclusions: Compared to PD, PSP demonstrates a more severe neuropsychological profile marked by frontal and visuospatial deficits. While neuropsychological findings increase confidence in differentiation, holistic approaches incorporate neurological exams and imaging. Nevertheless, comprehensive neuropsychological assessment, integrated with motor and speech markers, can improve diagnostic accuracy, early intervention, and differential diagnosis across diverse populations.
Abstract Progressive supranuclear palsy is a rare and rapidly progressive neurodegenerative syndrome. Clinical manifestations are heterogeneous and include Parkinsonism, postural instability, oculomotor dysfunction and cognitive impairment, with 80% of patients progressing to dementia within 3 years. Cognitive impairme...
Timothy P. Siejka, K. Bertram, H. Butzkueven et al.· Movement Disorders Clinical...· 0 citations
Objective: Neuropsychiatric symptoms (NPS) are common across parkinsonian disorders. Symptom profiles vary by diagnosis and stage of disease, and individual symptoms may differentially affect everyday functioning. We evaluated the impact of NPS on functional status in Parkinson’s disease (PD), Lewy body disease (LBD)...
Andrea Collins, Jordan Kozuki, Lily Wilkin et al.· Archives of Clinical Neurops...· 0 citations
The role of neuropsychological evaluation in identifying patterns of auditory verbal agnosia, nonfluent aphasia, and motor speech impairment consistent with a neurodegenerative parkinsonian etiology such as Corticobasal Syndrome is demonstrated.
Kailyn Bare Villarreal, J. Thorn, Claire Delpirou Nouh et al.· Archives of Clinical Neurops...· 0 citations
Objective: Category but not letter fluency is diminished in Parkinson’s disease (PD). It’s unclear if these findings extend to subtypes defined by type of initial motor symptom. Individuals with an initial non-tremor (NT) motor symptoms (rigidity, akinesia, postural instability) tend to have greater cognitive deficit...
Madison L. Wheeler, Mikayla R. Racine, D. Seichepine· Archives of Clinical Neurops...· 0 citations
BACKGROUND
In patients with fluctuating Parkinson's disease (PD), treatment decisions predominantly focus on motor complications, whereas neuropsychiatric symptoms are often regarded as static. Neuropsychiatric fluctuations (NPF), however, are frequent, can rival or exceed motor symptoms in their impact on quality of l...
M. Sousa, D. Amstutz, E. Natera-Villalba et al.· Movement Disorders Clinical...· 0 citations
Parkinsonian syndromes are increasingly recognized as part of a heterogeneous spectrum of Lewy body diseases, ranging from Parkinson’s disease (PD) to dementia with Lewy bodies (DLB). Identifying early markers of clinical heterogeneity remains challenging.
To investigate whether striatal dopaminergic denerva...
Sara Varanese, M. P. Buongarzone, S. Viola et al.· Frontiers in Neurology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.